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INTRODUCTION
Diabetes has been known for centuries with the clinical
pioture bemg kn01V!l to professional men and laymen alike.

Time

passed without any knowledge as to what caused this disease,
and it was not until 1889 that it -was even known that the pan
creas was the .Bite of the cause tor the oondi tion.

Thir'ty'-three

years later Banting and .Best produoecl insulin, 1'hioh··,has beeome
the treatment for this diab4tic condition.

Even though it has

been found that insulin is the treatment, the cause has still
not been proTen.

Thia is just another example in meclicine

where the treatment is found before the oause.
It is cOJ111110nly believed that the diabetes is aotually a
disorder of carbohydrate metabolism were sugar thus accumulates
in the blood and appears in the urine whenever it reaches a
certain blood level.

The insulin administered readjuets thie

disorder to lower blood sugar ievels and eliminate the glyoos
uria.

What is behind this disorder ot metabolism. has merel7

been theorized upon, with different theories having been devel
oped by different investigators.

Heredity is held to play a

large part by many men, end over indulgence in food and obesity
are considered to play etiological parts.

NerTOus and emotional

taotors are listed by some as precipitating factors and in:feotio-n
is thought to be important by some men.

lndoorinopathiea seem

to pla7 a large part in many caaes according to some invest
igators.
In order to arrive at the cause of diabetes by a more
sc ientifie method, certain inTeatigatore have produoed

---
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diabetes experimentally .

Mehring and Minkowski produced diabetes

by means of surgical removal of the pancreas in 1890, and this
was . confirmed by Allen by a similar method in 1914.

Another

method was found in 1932 by Houssay, Biasalti, and Rietti
who produced diabetes with injections of anterior pituitary
extract, this being confirmed by Evans , Meyer, Simpson, and
Reichert in the same year. (1)
was

This anterior pituitary diabetes

charact~r~zed by the pathology in the pancreas of degran•

ulation of beta cells , hyaliniz~tion, hydropic degeneration of
the cells, and reduction in number of cells . (2)

Of later

years has been the production of diabetes by injection of alloxan
a chenrl.cal compound.

This alloxan diabetes and its relationship

to the etiology of human diabetes are thus covered in this
paper .

ALLOXAN

-r-

atomic weight of 142. l .

H

o::.C
I

Its structural formula

is as follows :

~-= o
c, :: o

I

H -IV--C.. ::o
Thus it actually is merely an ureide of

(3)

mesoxalic acid . (4)

It occurs in two crystalline forms, one having only one mole
of water in combination with it, which produces small , colorless crystals · and one having four moles of water, which produces
. large, colorless, efflorescent crystals . (3)

The chemical

compound melts at 256 degree s Centrigrade, decomposes at 170

( 3 )

degrees Centrigrade and is easily soluble in water and alcohol .
(5)

Having four carbonyl grcups , it is chemically very active ,

being a strong reduction- oxidati on

agent , having strong oxi•:· .,

dizing agent activity because of the presence of the hydrogen
acceptors , and showing strong af finity for sulfhydryl groups .
It produces alloxa.ntin on reduction and parabonic acid by oxidation. (6)

Hydrolysis of alloxan results in urea and mesoxalic

' acid. (5)
Its chemical nature thus relates it to the purines , and
especially to uric acid , from which it can be produced by
oxidation with nitric acid. (6)

A lloxan is unstable in alkaline

solution, but is stable in acid solution, being stable for several weeks in glacial acetic acid and in five percent acetic
acid. (7)

It has been proven that at any pH higher than 3. 5

it is unstable and decomposes rapidly. (8)
Its presence can be demonstrated by one of several analytical methods .

One method is by its ability to reduce f erri-

cyanide in cold solution. (9)

Other methods are by noting its

turbidity when it oxidizes hydrogen sulfide , its color with
reaction with copper pyridine solution, its color with reaction
with alpha- naphthylamine , its precipitation of oxaluramide in
presence of ammonium cyanide, and then its reaction with potassl•'
cyanide in a weak acid or aljaline solution.
method it is possible to do

0

Using this latter

uantitative analysis of the presence

of alloxan by trimetric means where check is made on the inc rease

of reducing action which results from the reaction and

( 4 )

by gasometric means where the amount of carbon dioxide evolved
is calculated. (8)
Alloxan reacts with certain blood oonstituents to produce
rather characteristic reactions .
alloxan, wi
acid form.

On

addition of urea to

slow evaporation allowed, crystals of alluranic
When amino acids are added to alloxan solution,

there is produced a purpuric acid salt plus an aldehyde plus
carbon dioxide plus ammonia.

The alkali of the blood converts

the alloxa.n to alloxanic acid, which is converted to dialuric
acid by the thiol groups 0f cysteine and glutathione in the
blood stream. (8)
Alloxan also seems to be related to certain enzyme systems
in the body, for it causes reversible inactivation of papain

an.a cathepsin,

inactivation of succinic

d ehydrogenase , and

inhibits the formation of the Robinson and Cori esters . (10)
In 1862 Baron Justus von Liebig published an account
desoribing Thomas Graham ' s experiments on diffusion of substances
through semipermeable membranes and reported in that year the
presence of alloxan in a specimen of mucous from the stool
of a patient sufferring from intestinal catarrh. (11)

Two

years later Lauer reported alloxan having been found in human
urine in pathological conditions and in 1876 Van de Vyvere found
alloxantin in the intestine of a patient suff erring from oxalic
acid poisoning. (12)

Alloxan is found in the vegetable kingdom

as alloxantin in the hydrolysates of beet juice, beans , and
other vegetables . (13)
In the last few years investigators have attempted to

( 6 )

determine if there is any alloxan present as suoh in normal
human tissues.

R. M.Archibald, using several methods for

detection, came to the conclusion in 1945 that if alloxan is
present in human serum, it is there in only an inappreciable
concentration, being in less concentration than 0.02 mg. per
one hundred cubic centimeters. (8)

In this same year J.A.

Ruben and R.S.Tipson, using the purple test for alloxan, found
that extracts of fresh normal animal livers showed a suggestion
of alloxan to be present but found none to be present in the blocil.
of the normal animals.

They found alloxan in the blood five

minutes after administration of alloxan intravenously and two
hours after administration into the gastrointestinal tract. (13)
These same investigators in a later publication found alloxan
to be present _in the livers of normal animals, as well as in the
spleen, brain, and thymus of animals and they demonstrated
alloxan in the liver, brain, abdominal cavity serum, pancreas,
uterine muscle , ovaries, and the thyroid gland of r.umans .

To

prove the presence of this alloxan both the purple test and the
Pyrrole test were used in their study.

In al l of this study

series both tests were positive for all organs mentioned. (14)
This is significant evidence, but in 1946 Tipson and Ruben
published a paper which suggests the use of caution in the
interpretation of these findings in the pnrple test, for they
point out that the

presence of iron in the tissue tested

probably is an interfering factor, for the presence of iron
alone will cause a violet color to develop.

Thus interpretation

of the purple test in the series of organs must be guarded

( 6 )

so as to not lead to erroneous conclusions. (15)

The results

still stand, however, that they did demonstrate the actual
presence of alloxan i~ the tissues with their other test, the
Pyrrole test, also .

So this evidence can, probably, be accepted

as trustworthy.

EXPERil!ENTAL PRODUCTION OF ALLOXAN DIABETES
According to Ruben and Yardumian, Curoi in 1891
found that there was a decreased pulse and increased blood
pressure in dogs and fro gs which were injected with alloxan,
and that soon after injecticn c0on-.ulsions occurred and death
was the final result.

Three

years later Lucini found the

lethal intravenous dose of alloxa.n for rabbits to be 0.3 gram
per kilogram weight . (16)

Time then passed by with no record

of the action of alloxan in animals until 1938.

At this time

there appeared a report by Jacobs that the injection of alloxan
intravenously into a rabbit in the dosage of 70 mg ./ kilogram
weight resulted in typical findings.

These findings were an

initial transitory hyoerglycemia followed by a hypoglycemia
with the result of convulsions occurring in this hypoglycemic
phase , and finally leading to death of the animals.

Further

experimentation proved to Jacobs that the animals could be saved
by glucose injection in this hypoglycemic phase . At 1;this time
no ,further study was attempted and no study of the pancreatic
islets was made, with the result that these findings went
unexplained. (17)

And they were to

go unexplained until five

years later when this was further discovered and explained,
quite by accident, as are many of our important scientific
findings .

...
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In 1943 Dunn, Sheehan, and McLetchie reported further
findings resulting from alloxan injection, and it was in this
work that it was discovered that alloxan produced pancreatic
islet lesions in the rabbit.

This was discovered while these

three men were conducting experiments to elucidrrte the
pathogenesis of renal lesions in the crush syndrome
mismatched blood transfusions.

ana

of

In their attempt to find sub-

stances to influence the lower segments of the renal nephrons,
they found uric acid

derivatives to be very effective, and

in routine testing found alloxan to be one of the most effective
compounds.

But using the dosage rel'.'uired to produce these renal

lesions, they discovered, to their amazement, that the animals
were dying with symptoms not of renal disease.

.'-"

Histological

sections showed these lesions to be located in the pancreatic
islets. (4)

Follo~~ng the publishing of this paper have been

multitudes on the production of alloxan diabetes, for after
this paper was published, it began to be decided that alloxan,
by this islet le:ion, could produce a new type of experimental
diabetes •
Following this first production of pancreatic islet lesions
in the rabbit, Dunn and McLetchie in 1943 reported the production
of alloxan diabetes in the rat.

In this work it was found that

there was produced the same islet lesions as found previously
in the rabbit, but they found hyperglycemia and glycosuria
in this series of rats, being a typical diabetes mellitus. (18)
Gomori and Goldner likewise produced a typical diabetes in rats,

.........,,

and in their series gave alloxa.n in the a.mount of 200 mg./kilo.

.._.,_.,

( 8)
weight intraperitoneally.

They found subcutaneous injection

would not produce a diabetes and found also that the hooded rats
in their series were resistant to alloxan in that they did not
develop diabetes with the dosage of alloxa.n they were using.
(19)

Also in 1943 Bailey and Bailey produced the necrotic islet

lesions and typical diabetic syndrome in rabbits with a doaage of
200 mg. /kilogram weight intravenously,(20) and the same was
accomplished by Dunn, Kirkpatrick, McLetc hie, and Telfer in
the same year with a similar dosage. (21)

Alloxan was given

to dogs in 1943, this being attempted by Brunschwig, Allen,
Goldner, and Gomori who produced diabetes and death in one to
five days with a dose of 200-500 mg./kilogram intravenously

..._,.

and hyperglycemia. but no fatalities with 50-150 mg./kilo.
intravenously. (22)

In the same year Goldner and Gomori

reported the production of a diabetic :-:ry,10:rome in dogs with
50-75 mg./kilo. intravenously, a hyperglycemio-uremic syndrome
fatal in 4-7 days with 75-100 mg./kilo. intravenously and a
fatal result within a few hours after injection with more than
100 mg./kilo. administraticn. (1)
As the publications began to appear in 1944, more articles
on experimental alloxan diabetes -v:ere published.

Alloxan diabet~

was described as being produced in the rabbit by Hughes and ·Nara
(12), Bailey and Bailey and Leech (23), ,}oldli.er and Gomori (24),
Hard end Carr (25), Dunn,Duffy, Gilmour; McLetchie, and
Kirkpatrick (26), Bailey,Bailey, and Hogan {27), and Brunschwig
and Allen (28).

..........,.

All of these workers ~greed that the

diabetogenic dose for the rabbit should be set at about 200 mg./

~

( 9 )

kilogram i.·,eight intravenously.

Bailey,Bailey, and Leech found

•

that repee.ted small doses would effectively produce the diabetic
syndrome and with 40 mg./kilo. vreight three times weekly for two
months, two out of three

experimental

animals in their series

developed diabetes. (23)
Also in this year alloxsn diabetes in the rat was studied
Quite extensively by a considerable number of

investigators.

The successful production cf al 7 oxan rlia';etes in rats vms report<t'l.
by Lackey,Bunde, Gill and :Iarris by usi,ng 200 mg./kilo. intra-

peritonealJy producing diabetes in sixty percent of their series
( 29), Hughes and llare ( 12), Stetten and "3cxep ( 30), Bailey,
Bailey, and Leech who using 200 mg./kilo. subcutaneously

......

produced diabetes in twe 1ve out

o:'.'

fifteen of their series ( 23).,

Hughes and Hughes who used 12- mg./ki]o. subcutaneouiiy daily
and thus produced the diabetic syndrome (31), Thora.good who
used 20 mg./kilo. subcutaneously for one to four days and
produced diabetes in three out of ten of their test animals
(32), and Ridout,Ham, and Wrenshall (33).

A lloxan diabetes

was produced in hooded rats in 1944 by Lackey,Bunde,Gill., and
Harris (29) and by Duff and Starr using 175-350 mg./kilo weight
subcutaneously.
A lJoxan

~~s

continued to be used in dogs, and papers

were published on this part of the subject by Goldner and
Gomori who used 50 mg./kilo. intraJrenously (34)

1

Corrasco-

Formiguera vc"ho used 100 mg./kilo intra.venously ( 35) 1 Brunschwj.g
and AlJen who used 100 mg./kilo. intravenously (28), and Ridout

.,...,.

Ham, and Wrenshall who used 150 mg./kilo intravenously.

( 10)

~·

1944 marked the year when alloxan diabetes was reported
as a successful attempt in the monkey b·,- Banerjee ( 36) and in
the eviscerated cat by Carkill, Fantl, and Nelson (37).
During the year of 1945 the experimental work on al1oxan
diabetes began to branch out.

It was in this yee.:r that new

animals were used for experimental production of al}oxan
diabetes.

C-oldner and Gomori produced alloxan diabetes in the

pigeon with 150-200 mg./kilo. (38) and Scott,H arris, and Chen
did likewise (39).

Scott, Harris• and Chen also produced

diabetic changes in the duck and rooster but no diabetic changes
could be induced in horned owls• ( 39)

Mirsky likevd.se produced

diahetic changes in the duck with 200 mg./kilo. intravenously.

(40)

._,..

Seiden injected frogs with 150-220 mg./kilo. of alloxa.n

and noted beta cell necrosis in the ~ancreatic islets (41)
and Houssay, Orias, and Sara injected toads with 200 mg./kilo.
of alloxan and likewise noted diabetic changes

(42). Another

report of the production of diabetic chan[;es in the hooded rat
was

ms.de by Ka.plan, Franks, and Friedgocd who used 200 mg./

kilo. of alloxan intraperi toneal1y. ( 43)

Dogs were used as

experimental subjects by Uoussay, 0rias, and Sare_ vino produced
diabetes with 100 mg./kilo. (42) and Housfay who used 100 mg./
kilo. intravenously and produced the typical response (44).
But even in 1945 the rabbit and rat were the favorite experiment4
subjects.

The production of this experimental alloxa.n diabetes

in the ra. bbit was reported by Goldner and Gomori again (45).
Leech and Bailey with 150-200 mg./kilo. intra.venously
Banerjee in a partially pancreatomized rabbit
~

(9),

(46), Thomas and

Emerson with 300 mg./kilo. intravenously (47), and Kendall.

,,....,,

( 11 )

Meyer, Lewis, and Victor with 100 mg./kilo. intravenously (48).
Duffy used insulin to treat the hyperglycemic phase and glucose
to treat the hypoglycemic phase and thus allowed his rabbits to
go into a chronic phase of diabetes in fairly good condition.
(49) (50)

The rat was selected as a method of study by

Goldner and Gomori in a further report of their continued
studies. (45), James and Friedgood who used 150 mg./kilo.
subcutaneously and produced diabetes in sixty to seventy percent
of their test series (51), Chesler and Tislowitz (52), and Lowry
and H egsted who used 150 mg./kilo. subcutaneously (53).

In

1945 Ruben and Yardumian came out with the revolutionary discovery that typical diabetes could be produced in the rat by
administration of one gram per kilogram of al}oxan into the

"-"'

colon and achieved as good results e.s with intraperitoneal,
intravenous, or subcutaneous methods of administration. (54)
By the end of 1945 it was fairly well established that
the diabetogenic dose for the experimental animals used was
as follows:
Rat

200-300 mg./kilo. Intraperitoneal

Rabbit

100-200 mg./kilo. Intravenous

Cs.t

150

Monkey

100-150 mg./kilo. Intravenous

Dog

mg./kilo. Intravenous

50-100 mg./kilo. Intravenous

Pigeon

125-200 mg./kilo. Intravenous

This diabetogenic dose was defined as

11

the dose which

produces sustained hyperglycemia and necrosis in the
pancreatic islets but no ds.ma~e in other organs in eighty

.._,...,

percent of the cs.sos

11

•

(5)

.......

( 12 )
The oral route was found effective in 1940 by Ruben and
Yardumian who produced diabetes in ten out of fourteen cats
with an oral dosage of 0.5 to 1.0 Q;ra!n per kilogra.c'TI wei ht. (55)
0

Then in the swne year these sar.i.e investigators produced diabetes
by injection of 180-250 mg./kilo. of alJoxan into the jejunum
or the rectum. (16)

_;;. lloxan diabetes was reported for the

first time by Harris, And,,rson, and Chen in the hamster (56)
and by Jarrett in the sheep ( 57).

Her but, V,atson., and Perkina

produced alloxs.n diabetes in the rabbit with 200 mg./kilo.
intravenously in the year. ( 58)

More work on the rat apr,eared

in the 1946 literature by Ra.mes and Dawson with 125 mg./kilo.
intra.peritoneal injections (59)., Bennett and Behrens (60),
Lazarow

.._...

and Paloy (ol), and Laza.row by himself (62) •

In all of the experi~ental work on this alloxan diabetes
one point has been,quite well borne out and discovered by most
investigators.

This is that there is a great individual

variation in response to the alloxan administered, meaning that
with a certain dosa;::;e., there is a difference in the pathological
changes and clinical course in individual animals in a test
series.

As a general rule, however, it has been fairly well

borne out that there

ms a fs.ir parallel between dosa,,;e and sever-

ity of the pathological changes and symptoms of diabetes., these
being more severe as the dosage is increased.
mentioned that this variability

It has been

probably depends on the

nutritional condition of the animal (4) and Kass and Saisbren
have rendered all the animals in the:lr series almost uniformly
susceptible to alloxan administration by ·withdrawal of all food

......,..,

........

( 13)
for a 48-oO hour period previous to injection. (o3)

Laza.row

exp la.ins this variable susceptibility to alloxan by a variable
content of glutathione in the individual animal's bodies. (62)
Certain investigators have decided that some individual animals
a.re refractory to the action of alloxan, and of these,

Kennedy

and Lukens (64) and Kass and fit:dsbren (63) are two groups of

workers.

This idea of individual susceptibility variation

thus goes far to explain the variable results found by many
alloxan investigators, and allov.-s the results and concilusions
of one to be compatible with those of another, if this fact
be so considered.
RESULTS CF ,\.LLCXA.N INJECTICN

It has been consistently brought out by all investigators

'-"

that the injection of alloxan produces a tri-phasic reaction,
this reaction consisting of a transitory hyperglycemia., fol1owed
by a. hypoglycemia, and this in turn follow13d by the resulting
hyperglycemic condition.

Evidence has 1~0L1ted out that this

initial hyperglycemia begins during the first hour after
injection anci reaches its peak after about two hours.

By

four to six hours this blood sugar has fal:ien to normal and then
to the hypoglycemic level, and then within six to twenty-four
hours has risen a.gain to hyperglycemic lev: ls, to reach its
l1ighest level by about the third or fourth day follm,ving
injection. (65)

Death cf the animal may occur in the hypogly-

cemia phase, but this is usua11y
ccnvulsicns. ( 49)

._........

.

preceeded by hypoglycemic

.Aninals can be carried through this sta.:'e by

intravenous glucose injections and the thi:rd stage thus :rea,.·hed.

.._,,..,_,

( 14)
(12)

Other animals may survive this hypoglycemic stage, only to

succumb in the hyper~lycemic phase, where the animal dies by
inanition.

Survival of these animals may be allowed if insulin

injection is resorted to. (49)

However, a majority of the

animals do survive all three phases, and do become typical
diabetic animals.

These ani::-:-,a.ls show hyperglycemia, glycosuria,

polyuria, polydypsia, polyphasia, and a loss of weight, the
che.racteristic symptoms of a typical diabetes me Pi tus. ( 5)
These diabetic animals can be treated wi. th insulin and kept
free of glycosuria (5) and likewise these animals can be treated
by diet alone, a high fat diet causing; the disappearance of
this glycosuria and development of no ketonuria when the fat is
a~ded to the diet gradually. (66)

._..

Laborai;r,ory vmrk on these alloxan diabetic animals reveals
an increased blood sugar, sugar in the urine, increased uric
acid (38), a typical diabetic glucose tolerance curve as
mentioned previously, a temporary decrease of blood glutathione
(9), and hyperlipemia and hypercholesterolemia if the aninal
gees on untree.ted. ( 48)

If the animal is allo,..,.ed to

go into

coma due to hypergJycemia, there is found an increased plasma
inorganic phosphate, and in the liver a decreased total acid sel+

uble phosphate, glycogen, seven-minute hydrolyza':le phosphate
and resiiual phosphate and a.n increased inorganic phosphate.
These f8.ctors just reverse the:nsel-ves after the animal is treate~
with high doses of insulin. ( 43)
As the diabetes progresses, soi:ne of the diabetic complic-

.....,....,

.

ations are prone to appear in these ti.1.loxe.:1 test animals.

t

'i:

t'
f:

t~

!

-✓,

( 15)

~'

A.~>1.onc· those described are cataracts (5), acidosis (5), coma

(23), and retinal hemorrhages (36), but no worker has
described any findings of neuritis, thiamine deficiency, or
arteriosclerosis in these diabetic animals.

Several reports

in the literature show that in some ani--::ials there may be

spontaneous recovery from the diabetes. (35) (49)

It is not

agreed at the present as to whether a.l] oxan diabetes interferes with the rate of grov.'th or not, for Chesler and Tislowitz
say it does (52) while Shipley and Rcc!llSfold hold the op,~osite
opinion (67).

In the diabetic anic2al there is found an increased

heart glycogen and a decre~sed liver and skeletal muscle glycogen. ( 29)
_;.

,,,,.,,

finding found only •:.i. th injection of alloxan :._nto the

alLnentary canal is the appearacne of alh1minuria the first
twenty-four ho 1:rs after injecticn, this indicating some renal
involvement• ( 16)

Eowever, it has been pointed out even v'fi th

parenteral injection of alloxan that there is some renal damage
this being seen when it is
sho1nn b

~

ci ven

in rather la.r ~e doses, and is

an increased non-protein nitrogen, which often prop;resss

onto an azotemia, a.l though there is usual.}y functiona.1 recovery

of these kidneys in thirty-one to thirty-four days. (60)

The

elevation of the non-protein nitrogen usually parallels the
severity of renal damage found ,n autopsy of the animals.

A rather separ~te field of alloxan diabetes has been studied
by Miller and Friedgcod, who in 1945 reported their findings after

adni.inistering alloxan ~arenterally to pregnant rats.

They found

that alloxan does pass through the placenta within one to two

._,....

.._,...,.

( 16)

..

minutes, bu~ produces no permanent diabetes in the offspring,
with the blocd sugar of the fetuses paralJ eling that of the
diabetic mother until parturition. (68)
A lloxen, thus, does produce a rather typical diabetes
with al] the syrnptoms of the well-known cia1·,etes mellitus.
The seve1·ity of the diabetes can be well regulated by
regulating the dos&.ge of alloxan given, for :tt has been fairly
well borne out by the worke:·s ths.t the severity of the al1oxan
diabetes, as shcvm by blood sugar response, is .. quite directly
related to the dosage of f1l~oxan given.
0 ui te

Thus it has become

a handy instrument in the hands of the resec.rch worker.
PATHOLOGY AFT~P i0lLOXl,J/ INJECTI, N

The results of the alloxen administr~ticn as s~o~n in the

·~

living animal's signs and blocd chemistry have .just b,en
described.

l'ow we come to the viewing of the results of this

adF1inistraticn as shown on autopsy of these animals after said
ad71inist::-e.tion.

·,·1e can see what avtually hap, ens to the

animal's tissues and orG~ns to produce the objective signs and
blood chemistry chan,e;es previously :mentioned.
·:;hen an ani· al injected v:i tha.lloxan dies, or is sacrificed
0

for vievint oi" its tissues, and an autopsy performed, the first
significant thing obserVed is that r:o pathology is noted
gDDssly.

Each organ in its entirity appears to have no

patholo::ical appearance.

"icroscopic examination is neces 'a:ry

to find the patholor;ical changes, end the organ "here this change
is most striking and physiologically important is the pancreas.
This pancreas s:iov:s the lesion to be loc2ted in the islet:"'

....,....,

0£

.._....,....

( 17 )
Langerhans, where there is found a necrosis and disapveare.nce
of the beta cells, uQth destruction of the normal architecture
of the islet, and with an absence of any inflammatory
meEining; there is no celJ ular infiltration.

reaction,

In these beta cells

there is degnnulation, reductL'.n of cytoplasm, shrinkage of the
cell substance, nuclear

pyknosis, and finally disappearance of

the beta cell from the islet. (61)

In each necrotizing islet

there are examples of each one of these phases, for the process
isgradual and constant, beginning with onl~r slight changes and
progressing to the final disappearance entirely.

The alpha

cel1s a.nd acinsr cells remain normal in appearance, al though
one worker has even reported se:,ing actual alpha cell necrosis
in one case (26), b.ut most men do agree on the inocous effect

....,,

of this al}oxan on these aJpha cells and acinar cells.

These

necrotic changes are observed most con:'·'.only in the central mass
of islet cells, leaving the peripheral eel~ s una.f ·ected in many

dases (21), although even these are involved in the necrctic
process in some reported cases. (18)

All beta cells are not

destroyed , f'or many normal beta cells appear scattered am.on~
the involved cel:.s, and in some cases the d,amage to the cell is
t 010ught to result in a reversible change, for some oft hese cells
are thought to be only partial1y damaged. (23)

Thus the

pathological change is the complex response to an injuricus
agent with some cells able to survive and some not able to survi"e
and under>?;oing irreversible damage to undergo necrosis and
disappearance from the islet.

Other pathological changes reports

to have been seen in the pancreas are hydropic degeneration

...........

( 18)

~

of the beta ce1·1s (23), vacuolization of the lining cells of
the small pancreatic ducts (34), hypertrophy of some alpha
cells (26), hyalinization of some islets (16), and mitosis

(23).

in occasional beta cells

Consilierable effor ;; has been expended and considerable
me..tedal is to be found in the literature concerning the
progression of these described patholoGical changes from
injection on to the final pat~'lolorr,ical :result.

The follov,,ing

is the series of changes as observed in the rabbit by Bailey,
Bailey, and Ho~an in 1944. (27)

As early as five minutes after

injection the beta cell nuclear ~embrane ½ecomes more prominent

than normal, and there is a beginninG las
evident t:1ou:;h slight.

._.,

of granulation,

This degranulation process continues

and by forty-five minutes there is a. beginning shrinkage of the
nuclei -,,ith the central cells becoming more closely packed.
By one hour the cytoplasm is becoming more scattered and less
dense and the nuclei of the celJs have beccme much more shrunken
with the result that by two hours the arc::itecture of the islets
has become . uite distorted.

Hypoglycemia be;~ins to se' in by

three hours, and by this time there is a pyknosis of the nuclei
and an irre?.:Ular cytoplasm formation, v~th the former mentioned
changes having pro"'.ressed f'urther in de ;ree, for this process
is grt,dua.l.

The islets have become smaller by four ho'irs, due

to coalescence of so~e cells, and by six hours some cells have
disintegrated completely, resulting in_ a decreased number of
beta cells in the islets.
Go:dner and Gomori whose

,._...,...

The process was further followed by
results are as fol ows. (45)

By

.,_...,..

( 19)
twenty-four hours most of the beta cells have shrunken and
within four to five days all the necrotic cells have disappeared
·;,-i th only rarely a pyknotic beta cell being seen.

Examination

on the sixth day revea.ls that the islets 1:-ok fairly normal

excep;

that they are smaller, and cont1;dn only alpha and a.granular
cells.

It is t::is appearance thats ..:'ound in the diabetic

animal.
The pat:ological lesion is thus a se=.ective necrosis of the
beta cells of the islet, this being either a reversible or
irreversible change.

Spontaneous :-ecovf:',ry may thus occur when

some cells have only under~one rev~:,rsible change.

This is

evidenced in some cases 1:)y the appearance of mitoses in the
bets~ cells which are regenerating. ( 23)

.....,

Pat~olo ;ical chan~es t,:re noted in other organs also, these
0

bei~ cui te important in the ks_ d.ney, f or they may be great
enough to produce an uremic death of the experirr.ente.1 animal
I

if the alloxs.n is $iven in large enough dosage.

It

will be

remembered from the first of this paper that the effect of allox an
on the kidney was what was first responsible for the studies
which lead to the discovery of the diabetogenic action of
alloxan.
The lesion found most com 1only· in the kidney is a
parenchY"ll.atous de~eneration of the lining epitheli'U.t~ of the
proxiri:al convoluted tubules, with re1>ul ting necrosis and
desouama.tion of this tubular ep=thelium. C:9) (57)

Exa:-nples

of all stages of this degenerative process are found in the

........,

allo>:an diabetic kidney, '>":i th the more diff'use necrosis

........

( 20)

~

only being seen with massive intravenous doses of the alloxan.
Reports !bn the literature are found where there is replacen.ent
of the tubular epithelium by a hyaline material (19) and also
where there are glycogen deposits found :_n the kidney tubules
( 5).

id th smaller doses of s.lloxan tram usually used there

seen to be no kidney lesions, so there is a.ppa~·ently a
nephrcto:z:iir dose which is probably greater than the diabetogenic dose.

These lesions in the kidney seem to be quite well

localized to the tubule lining epithelium, however, one report
has mentioned a. -:nild con,resticn snd sv:elJ irn,: of the ":lmmerular
'~-·

•-✓

tufts in several experimental ani-rnals. ( 55)
A rather comir,on findin.ts is the appes_rance of parenchymatous
degeneration in the liver (29) as wellas fatty infiltration

,_.,

of the liver (65) (?3)

Dec::enerative changes range from mere

hydropic chano;e, chro,atolysis of nuclei of the hepatic cel1.s,
and so:ne fa-c y degeneration to a :-_-.ure focal necrosis, the
necrosis beins distributed uniformly thrcughout the liver
substance ,d th intravenous al 7 oxan administration but being
merely subscapular necrosis ,,i, th intraperi toneal injection. ( 61)
This necrosis usually begins as a coagulative process and then
becomes a

7 iquefactive

necrosis as the ,recess continues.

Con :estion of the sinuso ·.ds is seen in many livers, and in all
cases ':here is f'ound a clecrec.sed liver glycogen content.
The diabetic condition is considered by man:" men to be
tied up v.:i th changes in other endocrine organs of the body
as well as the pancreas, so considerable effoi,t has been
expended to l·-·ok for

...........

dhological c he.n.c·es in these organs

........,..

( 21)
as well as physioloq;ical changes produced by these organs
with this alloxan diabetic condition.

Iio chan'ses have been

observed in the thyroid, parat~wroid, and posterior lobe of
the pituitary ~land, and ,nly in one case an incidental
finding of con~estion in the thymus. (4)

The adrenal gland,

Hov:ever, s:101·,s s ome chan9:es 'Hhich have been observed '-yy
several ,··orkers.

'The most com:-::.on finding is a diffuse and focal

necrosis of the cells in the adrenal c ortex, this being seen
in all layers exce: t the zona glomerulosa.

( 49) ( 50)

Tr1e medullary :;iortion remains normal in ap-oeara.nce in most
cases, but even fragmentation and shrinka.~e of cells in t:1is
layer has been observed in one .case. (25)

Besides this

commonly observed chan'!,e, there may be congestion in the

...,

adrenal cortex, a swelling; of the entire gland, and appearance
of hyaline material in the cortex.
Likevnse, changes have been observed in the anterior lobe
of the pituitary gland, these chan,·res being observed. to any
degree only in the basophi ·. ic cells.

These changes are :aade

up of marked degeneration of the b,,sophilic cells, ·with
aevere pyknosis of the nuclei, de~rfµlulation

of the cytoplasm,

and even co~plete necrosis of these cells. (55) (57)

These

chrn:es are more apparent v:ith amounts of aHoxan grer~ter than
the dia:::ieto:;enic do: e, however they ares till present, but to
a less degree of severity, with the administration of the
diabetogenic dose.

In many cas,c,s the pituitary gland, as well

as the e.drenal, are ·lcrmal in ap:-eara.nce and microscopic
section •

............

l1

il

Iil
,[

,....,.....

t

( 22 )
This is al2 the pathology observed in the dloxan diaoetic
animal in the majority of cases.

Single observations include

the reporting of the appearance 0f pulmonary edema with the
injection of alloxan ( 56), the formation of a.sci tes when al) ox ,.n
0

is injected with cyteine (76), and muscular atrophy ~~th this
diabetic condition ( 32).

In the pigeon a rather curious

conditicn : esults from the allox;n adm.inist::ation, for besides
the production of the diabetes ,dth · its chan;;.cte:Hstic
pathological lesions as d2scribed heretofore, there is also the
production of the condition v:hich rernmbles gout.

In the

pigeon the serous surfaces and the kidney become covered w~th a
t'.'lin, -.,.-hite 12..yer of sod".um urate, and the kidney beco~nes involved.
in a massive infiltration with this sodium urate, resulting

.._,..

in the condition which has been given the nrone visceral gout.
( 38)

JV!ECE.:.'NISl' OF PHOJUC'l'ION
Up till this point v e haver ecorded the symptoms and sig}ls
0

and the patholo[ical findings of alloxan diabetes.

It now

becor::.es neces '. o.ry to see ~1ow t is alloxsn diabetes is produced.,
w'.;ich '.:ill i:!:1clude finding out ho,.; the syr:iptoms and labore.tory
find.in:;s a re produced £,.nd then trying to de<}ide how al~ oxan
administrs.tion does actu&..11y ~;roduce chan,:es to cause t ,is result
of alloxun diabetes •
A lloxan itself ~Jrob""bly produces a physicloo;ical change
in the islet cells which results in beta cell necrosis as outlinood
in the s~·ction on pathology.

T is alloxan ·:.,hen inject d is

quickJy destroyed, bec3.use the blood is alltaline and alloxan

.....,,,__,

.

,,,__......,,..

( 23)
is decomposed rt:--!:',idly Ciy
0

3-Il

alke.line medium.

This destructicn

of alloxan has been s ovm experinentf;lly by the addi t:'i.cn
of whole blood or plasm to an alloxan 11::~mple ( 45) and the rapid
destruction in the experimental animal body is shown by
,uantitat.ive analysis of the blcod after i:pjection, for only
one-tenth to one-third of the fil'lount inject 3d can ·oe detected
in one to two minutes and only a trace in five minutei. (9)

•

In addition to the alkalinity factor, there is also destruction
of the alloxan by glutathione to some degree, this being
e.cco':'Flished by interaction bet-:.·een the alloxen and the sulfhydrj.
-:;roup of the 0 lutathione.

After al1oxan a d"'.lli.nistration the

glutat::iore level is noted to decrease rapidly, "'l'hich substr,.ntie.tes t:1is theory of glutat~1.ione activity. (9)

.._...

Jc:vidence

in the opposite is t:u:.t tl:is destruction may not be so r .:.;.· id
~s thought, for E<l1oxan _'.,i ven orally and into the gastrointestind trsct directly passes throu; :h the :,:ortal circulatory system
0

and thus to the pancrec:.s, resistir.g n,,utra]ization for suf,'icient
ti::1e and' in suf icient concentration to cause pencreatic necrosis
as ',oted before. (14)

However, further proof tha.t neutralization

does ,; lay a part has been reported by Gomori and '}olnder who
lig;:;.ted the blood suprly tc the pancreas temporarily, injected
the alloxa:~, and then later reestablished the blood supply to
the pancreas.

In no case did they ~et a diabetic condition

when this ligLtion was allov:ed to remain fer any time at all,
acid.in.'-'. furc-her evidence that neutralizatioL of alloxan does
exist, and c.oes play a part in this story c,f s..l loxa, diaJ:,etes
production. (70)
~

~-

( 24)
·f';"hat probe.bly happens is the,t so:ne alloxan does set to
the pancreas after escapin~ neutralization. (45)

Here it

acts on the islet beta cells directly, prod .wing the necrosis
1

by some process, ,~·hether it be enzyme.tic, chemical, toxic, etc.
This alJoxan must be in a cert::dn concentration to cause this
damage, for in an a.mo .'.nt ')elow this concentration there seems
1

to be insuf icient damage to cause production of the diabetic
state. ( 14 )
genic

Thus ther,· is here an e:,.-p lane.tion of the diabeto-

dose previously mentioned.
7fhy this al}oxan should specifically &fL'ect the beta cells

is rather hard to explain, fort hey comprise ,nerely 0.007
percent of the total hotly ·weight. ( 20)

Possibly the best

way to explain the selective action is by means of a

.._...

.

protopl&.smic su[ ,eptibili ty of' these cells of the _'.)e.ncrea.s to
the a 6ent, ~ihich may be explained by the s )ecialisation of
the function

of these cells. (4)

A

specL,lizs.tion of

enzyme system also may fit;ure into this specific necrosis in
sc:;10 way not as yet explained sufficiently. ( 62)

.\hatever the

rea. son for t!1is specialization it is true that the alloxe.n
does act cirectly on the beta cells to produce the pat'.:,.ology
seen.
But nov1 hov: does the o.lloxan produce tuch a profound change
in t~is small beta cell to cause necrotic chan~es?

Here one

comes to a group of theories, none cf whieh are acce··ted as
the r,ns wer at the present time in its entirity.

The process

of this alloxen-produced necrosis is not yet krwwn.
advocated by Dunn in

,,,_._..,..

One theory

his first v,crk on alloxan, but no longer

( 25 )

~~

held as even possible, v,as that the all oxan causes overstimulation of the islet cells, producinr, overstrain and overwork of the cells, which finally were overworked so much that
necrosis set in. ( 4)

Tl.. is has since been proven by many as not

even fundamental'y true. (24)

Frobably the easiest explanation

to believe and the simplest to derive is merely to call alloxan
a cytotoxic arug and to leave this to explain this action. (16)
Some :nen have devised their ovn theories of the action of
alloxan.

In 1945 Leech and Bailey observed the slutathione

destruction of allcxa.n and postuls.ted that since it was the
sulfhydryl group of glutathione that was involved, cys ::.eine
also night be involved.

They further postulated that since

cysteine forms an in-te:~ral 1:·art oft he insulin molecule,

.,,__.

alloxan might cause a disturb2.nce of the cystine-cysteine
equilibriu.,n tor esu 1 t in the production o:' this diabetes. ( 9)
Hughes and Hughes have decided that only 0he senile beta cells
succumb tc the allo:~e.n, which disturbs the physiological
e,uil:ibrium and hastens maturation and enlargement of the
replacing young cells in the islets.

These youn~ cells resist

the toxic effect of alloxan for a considerable a..moent of time,
out finally become senile also and a.re also destroyed.

The proc-

ess of destruction of senile cells and ma":uration of "Oung cells
continues until the ability of the pancreas to i:.:roduce new islet
cells is exhausted, thus the amount of islet tissue decreases
and the animal becomes diabetic.

They conclude that this

theory is consistent v•i th the patholo,~ical findings of
abnc:!."mal islet cells in the islets and also with the blood

,,,_.:,,,,,,..

........
( 26 )

sugar curves noted durins the develoi:;ment of this
nel itus. (31)

diabetes

iii th all the "''ork being done on enzymes at the

present, Lazarow in 1946 has attempted to explain the action
of alloxan on the enzymatic basis.

Re noted that alloxan

combines ·:rith su1fhydryl t:roups cf proteins and knoo·,.i.ng that
enzyme systems require sulfhydryl groups for activity.,
postulated th;;;.t the beta cell necrosis might result from
enzyme inactivation by al1oxan.

Further work indicated to

him that v,hen adecuate sulf'.1ydryl ~roups in the form of cysteine
or glutathione ··ere given
was seen.

i th alloxan, no beta cell necrosis

This meant to him that these compounds protected

the sulfhydryl ~rou~s of the islet cells from inactivation by

,,_.,

means of administration of a large amount of exo~enous sulfhydryl conpounds to react -,-i th the alloxan instead.

Thus he

went on to explain the action of alloxan on the basis of the
alloxan taking up of

cell enz:r.ne

sulfhydryl rroups,

explaining the islet cell specificity b-

the fact that these

specialized cells probably required active sulfhydryl groups
to function while les

specialized cells could 1)ass through

non-sulfhydryl pathways. ( o2i

Further vrork v.rill ,Jrove

this to be a po sible true explanation or else just another
false step.

This work on ir~ibition of the diabeto~enic action

of s..lloxan as shoYn in Lazarow' s "'ork if further substantiated
by some ,rnrk by ~i{ein:';la.si Frame, and <illiams which came out the

year before this work of Lszaror' s and . lso so;ne ,york by Bs.iley
andLeechv:hichcame out the s&.me year. (9)

.__.,,.,,,

.

Less than diabeto~

,.._.~

( 27)

genie doses of aL'.oxan are noted to produce some dama~e short
of that necessary to produce the diabetic syndrome, but repeated
doses oft his produces, in ti,.,e, _atholo,ey suffici::mt to produce
the diabetics tate, which indicates that the action of alloxa.n
on the pancreas

&a a cumulative action. (64)

Spontaneous

recovery of the allozsn diabetic animal rasbeen explained by the
fe.ct t1Et enough beta cells recover from dai"!laze short of necrosis
or else the small number cf cells excaping injury under go
hypertrophy and hyperplasia to produce a functioning; is-let.
"i'Lich is the right explanation is not ~:norm at the present
time. ( 49)
Some work suggests that this allox,,n diabetes is not wholly
pancreatic, for adrenale ;tomisation of the alloxan diabetic
0

-....,

animal causes

0.

marked reduction or complete diaappearance of

all dia'oetic sic;ns. ( 51)

T'.lis is not proven yet, ho·::ever,

to be true in all cas:';s, for other ·;;orkers indicate that the
pituitary aJ1d adrenal play n,o part in t:~_is diabetes. (47)
:More v;ork must be done

in the future to decide if any

other

orguns are actually involved besides the pancreas in this
condition.
The renal lesions have been explained by the concentration
of the tozic &.gent in the tubules in the proces.s of excretion

(21) and seem to be related to the higher doses of alloxan only.

(61)

The liver lesions probably result from the detoxification

process of alloxen or some bre~"kdovm pz,oduct of alloxa.n in this
or:;2.n. (58)

.... ,,.,

..

Now as for explanation of the diabetic symptoms and signs,

.,.,...,...

( 28 )
it beco.~1es a controversial point as to the explanaticn for
the mechanism it}. the

initial hypern;lycemia and the hypo-

glycemia which occurs in the three-phase reacticn to alloxan
adm.inistration.

:ft is, how3ver, v.-ell e. z.reed th&t the final

permanent hyperglMcemia is due to low insulin production
follo••,ilig the necrosis of the islet beta cells, which do
produce thd.s

insulin. ( 42)

This hyper f:lycemia results in

_;lycosuria due to _presence of glucose

in an amcunt over the

threshold ..:.mount, polypypsia due to excess water excretion in the
excretion of the sugar, and polyphag;ia.

All oft ~isi s

explained and acreea by all observers prinarily as the result
of the low insulin content of the necrotic pancreas,
But when it comes to the explanation of the initial, tra.n-

.._.,,

.

si tory hyperglycemia., mo:::·e dispute is noted.

The most popular

theory is that it is due to ext,"a t:lucnse mobiUzation by
:;lyco~enolysis which is caused 'cy epinephrine liberation upon
adrenal cortex stimulati~n by the alloxan. (5)
explained as occurring b,, this nechanism by

This phase is

Go}dner (5)., Dunn

(4), Hughes and !are (12), Gomori (12), Hard and Card (25)., and
Joslin

(73).

This has been decided to be the mechanism after

experiments have shovm that insulin prevents this hyper:lyoemia
and adrenaleotorr.y prevents it lL~e,,.d.se. ( 5)

Plotting of the blood

pres:::ure curves oft he animals Ecfter alloxan administration show s
an increased blood pressure, which substantiates this adrenal
stimuls.tio:n t~eory. (25)

It has even been suggested that this

hyperglycemia may be a non-soecific reaction seen "Nith the

.,,_,.,,.,.,,,

( 29 )

~

injection of any sulfhydryl group containing compounds. (37)
Houssay, Orias, and Se.ra report that this phase is not seen
in a hepatector,lized anical and is observ,,d in adrenaleci:omi~ed
anL~als and animals with section of the nplanchnic nerves.
They conclude that this process is not the result of c.drenaline
~

cortical hormone stimulation, but th::.t the Jiver is the

responsible orgm1, there being an action on the liver directly
by the alloxan. (42)

Tbere have be,,n no other observers

making ro:J.Y such sug:;estion, so thisreport remains as yet unproven.
One report, however, does sug est that this action· on the liver
does not occur directly, but that alloxan may affect the liver
via the nervous pathways to produce the initial hyperglycemia.

....,

Brunschwig and i:.llen su 6 est that it may ,e due to nei:raralization
of insulin by the alJoxan ~~th an outpouring of glucose into the
blood from the tissues (28) but this s also a theory

which

remecins unproven although most wo~kers agree that alloxan does
not neutr lize the action of insulin.
The nechanism of the hypodycemia has been explained by
worke1·s w'1o group themselves into b:o main types cf' thinking.
Cne contends that the beta cell necrosis is the result of escess
i:asulin production J.nd cne contends the.t the excess insulin is
the result of the necrosis.

YJun..."1 is the o:1ly v.-o::ker that still

contends the first to · e the cs.se.

It is ·1is theory that the

alloxan stimulates the beta c.ells to excess function, producing

excess h!sulin to produce the hyposlycemia, and the hyperfunction results in time in cell necrosis from ove'""mrk. (4)
The latte
~

.,.,,,-

gro 11p if comprised of Kenne·y and Lukens (640,

..,_,....,..

( ;-50 )

Goldner (5)., Hughes and !e;;.re (12) , Banerjee (46), Gomori (72).,
and Duffy ( 50).

The theory v,':lich these men contend to-, e true is

that the alloxan causes a beta cell necrosis which results in
cell disintegration., this insulin in the c 3ll beins liberated
1

into the blood stree.rn rhen these cells disintegrate., thus
ca.using the hypoglycemia.

It is~rgued that the pathology is

degenen.ti ve from the first, and that the hypoglycemia is the
first sign of the necrosis of the cells, ar,d these workers
fall on this as procf of their theory.

(5)

Further pro6f is

added 1:hen they experinentalJ~ shm·:ed that there is an absence
0

of the hyposlycemia in a pervi~us diabetic animal. (64)

Thus

this latter group in the majority are probably adhering to the
correct explanation for the r:iechanism

._.,,

of the production of this

hypoglycemic phase.
Cther theories have been proposed for ~his hypo~lycemia.
Houssay, 0rias, and Sara ac:ain

try and explain it by the

theory ths.t the liver alone is ese:ential in this pdse., and that
it is due to lack of glucose produced b,

he liver (42) but

this theory has been , ui te easily discarded because i t has been
srww:n repeatedly that the pancreas :must be pres"nt in the animal
to produce this hypoglycemic ph~se. (33)

Brunsch~~g and Allen

contend that it is due to a compensc,ting oversectetion of insuli:1
by the islet cells during the initial injury (26) but again
rememberL:.g the.t the process is de,,:enerative from the begim,ing
nuts t¾is theory in a bad light also.
.A. final theory on these phases has been e.dvocated by Dunn,

-..-

Kirkpatrick, McLetchie, and Telfer, v,hich attempts to explain

( 31)

..._.-

the first two phases by a cornnon process, ins~es.d of by two
entirely separate procesl:'es as have been just described.

They

postulate that with al:' oxan injedtion there is produced an
increased glucose ~oTuilizaticn and also an increased combustion
of sugr,.r, vti th mobilization ge ~-i::in<s ahead first producing the
initial- hyper ::'lycemia and then ccmbustion ge-:.;ting ahead, to
produce the hypoglycemic phase. (21)
~.-ii th all this work on alJ oxan, the hardest thing to explain
has i,een the specific ac cion cf e.lloxan on the
islet eel~ s.

pancreatic

·:i th this in mind, many atte'."!1:;its have been made

to use clo.c:ely 8-ssccic.ted chemicals similar to alloxan, attempting to see if any chemicals other than al) oxa.n can thus ~-roduce
similar results.
~

Thert:c have been no re::ul ts vri th the fcl· o,<.'ing

related chemical ccmpounds:

mure::ide, cytosine, iso-cytosine,

barbituric acid (45), dimethylalloxanio acid, violuric acid,
tartaric acid, alloxanic acid, isatin, ninhydrin (74~, uric
acid, urarnid, parabonic acid, benzalbar>:i turic s.cid, 4-amino
2-thio uracil ( 32), isodiaL.:.ric acid, mescxalic acid, oxe.luric
acid, l'orm~dur a (17), sodium nesoxalate, ethyl mesoxalate,
mesoxahc::::ide, i,.nd benaaylene urea ( 75).

There is so:,,e dispute

about the diabetic action of several other related compounds.
Dialuric acid, the r eduction product of alJ.oxan has b_er:n reported
to have no alloxan-like effect by several

·workers ( 38) ( 5)

but gas been shown to produce diabetic ch8nges also by
experimentation by othe,· men ( 7 i).

Likevtlse is the case w-i th

alloxantin (5) (76) (77) and stryl- riuinoline (5) (4).
Hethylalloxa.n, dimethylalloxantin,and methyldialuric acid have

.........,.

( 32)

.__,.,..

been reported in one case to be diabetes producers (24) but no
other reports to ·rove or disprove t~is have been found in the
literature.
All

of this work has been v:ith the purpose to try and find

the structure of the chemical which is necessary to produce this
pancreatic necrosis.

It has been decided that the structures

essential are the pyrimidine ring, an oxidized form of the
molecule, a labile hydrogen atcm attached to the nitroq;enatom,
and t·xo nitrogen atoms of dif""erent basici ty joined by a system
of conjugated double bonds.

The fact that the compound is an

oxidized a:,_:ent is not respo~~sible Bor the a, otion ·in any vray. (75:'
SIGKir'IC~J·rc:::; CF ::.LL0X,1N DI ;~BETES
'.,;ith the advent of these alloxrui studies, it has thus

......

·oecorr:.e

&.

nevr means to study the disturbed marbohydrate metab-

olism and a new and easv vmy to produce diabetes .:::ielli tus
experimentally.

Using aP oxan, workers have studied the changes

in car½ohydrc.te metf..oolism in diabetes ( 30), the effect of
pancreatectom"· upon diabetesand its co-x.plications (78),
t~iamine requirements in diabetes (59), the effect of diabetes
on tissue oxidc.tions ( 79), changes in liver glycogen in diabetes

( 80), the thyroid inf1uence on diabetes (SJ.), dextrose tolerance
in diabetics ( 82), the rele.tionshilp of the adrenal gland to
diabetes (83), and the formation of ~lucose in a diabetic liver
( 84) •

,,llox2.n has proven a valuable aid in helping research men

try and aiscovar mhee a0out the details of diabetes and its
complications.
But more inportcnt yet is the relationship of al1oxan to

,....._,

...,.,.
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hum.an diabetes, for nany workers have bee,'Uil to think that it
maybe the basis behind the long unveiled cause of

diabetes.

Others, of course, believe it is not an influencinG factor.
But ,·e can do we 11 here, as a final point, to try and view
the intire field of al1oxan diabetes e.s it is rel8ted to hunan
diabetes.
RELATic,t;SHIP TO ffiJ1cAJI: DILBETES

Yne course and patholo~y of alloxan diabetes have been
previously outlined.

A striking point ·which should be noted

by all is thatalloxan diabetes is very similar to human diabetes
in many ways.

Alloxan diabetes, if allowed to run its

course untreated, resembles human diabetes in its acute form
"l'frcile if it is treated resembles the chronic form. (49)

"-"

Gne should note first the clinical find.ing:s of the e.Eoxan
diabetes that resemble t~rnse found v.ith a normal human diabetic.
These are hyperrlycemia, g)ycosuria, hyperlipemia,polydypsia,
polyuiia, acetonuria in some cases, polyphagia, the characteristic
delayed sugar clearance and hypercholesterolemia in some cases.
Both types e.re sensitive to insulin hut neither is a.ctuall7
oured ,-,"i th t.1-te insulin course and both can be control 1 ed Yri th
diet, the glycosuria decreasing as the fat in the diet is
decre scd and also ca.n be decreased if the animal is caused to
fast. (85)

Similar complications a.re noted with both alloxan

diabetes and human diabetes, these being ca.ta.tacts, increased
susceptibility to infecticn, acidosis, coma, weight loss, and
retinal hemorrhages (86).

Thus far both follow'a very close

similarity in cl h!ical course and progress.
~

....

'

Patholoey is rather

i
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a diffe··ent picture, ho, ever, but it tooshcv,s very iYr1~Jortant
similarities in some cases.

The usual patholo·dcal appearance

of a hu:!'!lan diabetic pancrez,s is one of fibrosis and hya.line degener9.tion

and in some cases appearance of some hydro::ic "'.egen-

eration, this of course being the appearance oft he pancreas
usual Jy ai'ter a chronic course.

If the course is more acute,

hydroric degeneration is more the ca. e • ( 87)

In some cases a

nor:!'!lal pancreas is noted and even insular necrosis and pyknotic
nuclei are to be noted in some pathological specimens from
,:u::-1an diabetics. ( 21)

The ':'atholr.c~ical appearance of alloxan

diabetes has been given previously and wL.1 nt,t be repeated,
but it, of course, is the ;,athology of an acute diabetes in most
cases.

..._.

;1..s mentioned previously, an alloxan diabetic pancreP.s

does shoY' some hydro'.)ic de 0eneration, and also 13ome hyalinization in some cases.

Tius even the pathology of alloxan diabetes

at times is like thid found v:-ith human diabetes.
The comparison betwse:i the two diabetic conditions is
easy then after these similarities are noted and considered.
Y1hether this similarity is accidental or due to the f2.ct that
both have a cor:,nicn cuase is a r:i.atter of mere conjecture at the

present. However, it is hard to disregard these similarities as
mere a::..cidental, -,,hen such a 17,roup of them become piled up in
favor of this similarity.
two 2.ren't similar.

Of course, some points are that the

Ther·· are no indico.tinns of neuritis,

arteriosclerosis, or pruri tis in alloz:an diabetes and likev:ise
:io indications of spontaneous recovery or beta ce ', 1 necrosis in
the human diabetic.
~

These, however, are net absolute, for

( 35)
alloxa.n enimals have not bren cbserved for a ,;;eriod

long e nough

for pruritis, arteriosclerosis, or neuritis to develop and also in
the hyman, pyknotic nuclei have been observed in a diabetic
pancreas and also

have a diminished nu�ber of islets. (18)

,'tith the remarks about these similarities in mind, one would

next like to know about the action of alloxan in the
human

body.

This fielil of kno1:Yled'e is limited as yet, for it has

been tried only in a few limited
in the presence
iBD.'t a
and

c as2s, these being only

of malignancy of the islets, whic h truly

fair trial, for the cells acted upon are not normal cells

thus may act dif ere�1tly.

Eov,ever, theresults,

even thour;h small, are vorthy of mention now.
Cwans, and Thrlrnton

Br,mschwig, Allen,

hs.ve s.ttempted to use alloxan clinically.

They postulated that since the radiosensitivity
of t he tumor paro.l}els the radiosensitivity

of the tiseuea

from which it arises, also a chemical affecting norm al tissues
mi;ht

also influem1e carcinoma of the sa.me tissues.

alloxan influences the islet cells of the pancreas,
attempted

Thus since
they

to tre�,t carcinoma of islet ce1-l v-ith alloxan injectio::.

'fheir fir;:;t c&::,e had symptoms of hyperi:nsulinism v;hich were
relieved with dextrose injection, but after a.lloxan
administration the

patient had irE:,rov ·ment in the fre'::uency

and n ature of these hyperinsulinism attacks, '3.1-::hcugh there was
,

no change of blood sugar noted.

repeatedly

Co\!1tH@ of alloxan were

given and e:,ch time the patient; was improved for a

time, but in time the patient suocu�bed to one of these
attacks.

.:.t autopsy there was no evidence of neoplasm W''ich

( 36 )

'-'WI

had been s,,o,m previously to be pre2ent by bic sy.
cel~s were to be n0ted
man is

in the pancreas.

ensitive to alloxan·,'•u.t seems

Nonecrotic

This case shews that
to be more resistant than

the dog or rabbit, rith less actual cell necrosis resulting.(88)
In another case these same workers administered alloxan to a
patient suf:ferrin.;- .from a s i!nilar islet cell carci.noma who was
!laving recur,·Emt attscks, '\'.'hich v.rere becomin 11; more fre uent
with blood su2:ar going dovm e.s lov; as fourteen mg. percent.
_:,.f'ter alloxan s..dministraticn his attacks became much less
uent and less severe.

fre, -

ro mention of patholosical changes were

menilioned, for-~ he patient was still alive at time of the printing
of the article.

These same men gave alJcxan to a patient

v,ith ce.rcino:ns.tosis and in this case the blood sugar remained

...,

normal and there were no pericds of hypoglycemia or hyper(';lycer.1ia.

_.:,;noeher patient ,.·:i th carcinomatosis was given alloxan,

and this patient e.ied dus to another cause, a utorsy shoring;
early degenerative changes in the islet beta cells. (28)

It

is thus evident that alloxan does have a rpecific action in the
human as wellas in the ex:oerimental animal,. as is shown
conclusiveiy by these clincil studies.
In the beginning of this paper it

~~s

mentioned that

alloxan t'robably does exist as such in the normal human body.
Thus since it has beendemonstreted that it is in the body ,and
that alloxan di8.betes is si.!llilar to human diabetes in many ways 11
how does the situation stand at the present in regard to the
role of ~~is chemical, al 1 oxan,
human die.betes melJ itusi

.........

in the production of

,....,
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N,any v·orkers on alloxan giabetes have noted the similarities menticned previously, and have thus tried to postulate
theories as to ho ,c: allo::-::an may be the cause for human diabetes.
0

Dunn, Kirkpatrick, McLetc:1.ie., and Tel~e:c mention that it is
their oninion that alloxBn m::,y cause the tni tial disturbance
of the islet tissue to cause diabetes.

-In support of their

theoby they advocate that since alloxan is so closely related
to unic acid and someof the purines., it could be elaborated
in the oody from one cf these compounds.

Uric acid is probably

the compound i'rc,m which it wouldbe formed., according to them.,
for it is concerned in muscle metabolism ,..nd other tissue
metabolism, and is ~lso derived from the nucleins and muscle
tissue in the food.

"'-"'

Thus alloxan might be formed and ~et to the

beta cells and destroy t:1em., a C'Ording to these workers. (21)
This theory is e1a:,orate43 by

them in a lete

report Y:here they

continue to postulate th1clt alloxan may be a horraone of muscle
w-iich is deschar :ced into the blood proportional to muscle
activity and keta.bolism.

Through this ther: is possible islet

cell stimulation and it s thought by them that this may account
for the exact a..."'1d re,pid retulc.ticn of blood sugar to be noted
in the body in spite of vast changes in the rates of storage
and combustion. (4)

Jos·1 in has similar ideas in relation to

the uric acid metabolism and production of alloxan in
relation to muscle tissue (6) and he also rtates that it is
L~pos~ible to escape the conviction that alloxan has brought
medical science nearer the explanation of diabetes than any
step :,itherto. (89) Viff:rcing this fact that alloxan is so

.,,_,,,,,._.

..__.

-

( 38 )

closely

related to physiolo~ical body substances, as purines,

nucleoproteins, and uric acid e specie.lly, Goldner ( 5), Gomori
(45), Hughes and '1,are (12), and Ruben and Yardumian (16) have
decided that al] oxan may b e the cause of human diabetes in
cases of derangement of metabolism ccncerning these compounds.
After deciding that e.lloxan can be the cause of the human
diabetes, Tipson and Ruben have further reported that al1oxan
causes the diabetes bec,.use in the body there is produced either
an overproducticn of alloxan by some metabolic process or else
an inability to destroy the alloxan once it is formed.

Thus by

either o~ these processes al·oxan can increase in concentra.ticn
sufficient to become cytotoxic to the islet beta cells and thus
ca.use necrosis and finally the diabetic syndrome. (14)

.._,,

As

mentionec previously, Lazar ow has ·worked on the protection
a~ainst alloxan by glutathione.

He has added to this theory

of Tipson a.nd Ruben that the inability to destroy a1·1 oxan
is brought about either by a generalized decrease of f-::lutathione
or else a metabolic defect of glutathione only in the beta cells
of the pancreas.
Some evidence, or rather a lack of evidence, points to the
fact that alloxan 1'.tay not be involved in this diabetic problem.
'This is that there is a lack of evidence that al] oxan plays any
role in physiological ,,recesses in the bcdy. ( 5)

But this is

not actually a very strong point asainst the pessibility of the
role of alloxan, for further work may disclose a11oxen to be so
involved in normal physiology, and even

at the pre~ent it has

been demonstrated that alloxan is present as such in normal

........

......
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human tissues.

Duff lists three reasons why he does not believe

that al oxan plays any role in human diabetes: no evidence that
it plays any part in ~;hysiclogical processes:r., rapidity with iwhich
it is destroyed nhen injected into the body, and the high hu;rran
0

resistance to it. (90)
accounted for.

The first of these has already been

The second of his i,aasons has been discussed

previousay in this paper, and. even though rapidly destroyed,
it is the case that enough escapes neutra:ization in suffieient
concentration to cause necrosis.

,\.s to the third, little can

be said, but it cmbe added that necrosis has been observed in
nan vdth alloxan administration as mentioned previously a...n.d also
there has been noted a disappearance of all carcinomatous islet
cells before death of a patient previously proven to have islet

..._,.,

cell carcinoma by biopsy.

Also in regard to his third reason,

alloxan a±-:iinisti·ation to a case v:i th islet cell carcinoma is
not ree,lly a fair trial u:-on

Y0hich

to base a. conclusion, for it

is not acting on normal i::ancres.tic tissue in this ca,,:e.

Thus no

very strong evidence poi ts to the fact t 11at al] oxan can not be
the cause of human diabetes.
Viev;ing this whole problem, it seems at present writing
that alloxan may be a good explanation as the causative factor
for human diabetes.

In support of this a re t~1e facts that the

alloxan and human diabetes ru:e verysimila.r in many clinical
and patholo2;ical aspects, that alloxen is closely related to
p ysiologica.l substances founc, in the human body, and that the
alloxsn mechanism of diabetes production can :)e -aie:-uately

...,.,..

ex?lained.

No evidence is lroc,vn at the -oresent tor efute this

..., __
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ste.tement that alloxan is the causative factor of diabetes mellitus.

Since no better explanation can be given to the causative

factor, e..lloxan seems to be at least the best one at the
present, both from theoretical, scientific, and practical
sts.ndpoints.
SU1!i\f.ARY

:~ lloxan diabetes has b,3en described fron all standpoints
in this paper.

The nature cf alloxan ani occurrence of alloxan

have been mentioned, and the history of the experimental
prcduction of alloxan diabetes has been :;one into in some detail.
The patholmgical appears.nee and clinical appearance of alloxan
diabetes are spoken of, and these are compared ,d th the s rune

in true human diabetes :1ellitus.

...,

Theories on the mechanism

of production of alloxan diabetes have b3en compared, and
finally the significance of ::i.l loxan diabetes has been
mentioned.
The point that remains tobe proven or disproven in the
ftu:i:nu,w is as to v.het:qer alloxan is the causative factor in

human di0.betes or not.

At the present, the mass of evidence

points to thefnct that it canveyy likely be the actual
causative fc.ctor.

Heasons ror this opinion

ave been given.

Future v,ork will show this state:-nent to be true or to be
false.

~
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